Publications by authors named "Debbie Gj Robbrecht"
Article Synopsis
- The CUPISCO trial is studying whether a new treatment approach called molecularly guided therapy (MGT) can help patients with a type of cancer called cancer of unknown primary (CUP) do better than the standard chemotherapy.
- This trial involved 1,505 patients from 34 countries and focused on those who showed improvement after initial chemotherapy.
- The goal is to see if using genomic profiling in deciding treatments can lead to better results in fighting cancer compared to the usual treatment options.
